InsiderTrades

Form 4 for BLFS BIOLIFE SOLUTIONS INC

Accepted 2022-01-24 00:00:00 ET · period of report 2022-01-20 · accession 0001437749-22-001523 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2022-01-24 2022-01-20 BLFS Schulz Marcus Chief Revenue Off S - Sale $30.24 -395 28.4K -1% -$11.9K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-01-20 S D 395 $30.24 28,391 D — —